Weekly Rundown: Key Catalysts for Small-Cap Stocks (November 10-14)

From recent disclosures to corporate shifts, we’ve highlighted the top small-cap catalysts to watch. Here’s your weekly preview (November 10-14).

--

American Association for the Study of Liver Diseases (AASLD)

The Liver Meeting® 2025, hosted by the American Association for the Study of Liver Diseases (AASLD), will take place from November 7–11, 2025, in Washington, D.C. This prestigious annual event serves as a global platform for sharing the latest scientific and clinical developments in hepatology. Experts from around the world will gather to explore cutting-edge research, innovative treatment strategies, and practical approaches to improving liver health.

Featured Presenting Companies: GALT, MTVA, CMMB, AVIR, THAR, GNFT (presenting on Monday, November 10)

Cantor Crypto & AI Infrastructure Conference

The Cantor Crypto & AI Infrastructure Conference will be held from November 10–12, 2025, at The Ritz-Carlton South Beach in Miami Beach, Florida. Organized by Cantor Fitzgerald, this event brings together thought leaders, innovators, policymakers, and investors at the convergence of digital assets, artificial intelligence, and energy infrastructure.

Featured Presenting Companies: FUFU, UPXI, STEX, DEFT, BTCS, MOGO, STKE

2nd Annual Guggenheim Healthcare Innovation Conference

The 2nd Annual Guggenheim Healthcare Innovation Conference will take place from November 10–12, 2025, in Boston, Massachusetts, USA. Organized by Guggenheim Securities, this highly anticipated event will gather healthcare leaders, investors, and innovators to explore the evolving landscape of healthcare technologies, therapeutics, and investment strategies.

Participating Companies Include: SVRA, CMPX, AKBA, NMRA, CYBN, PYXS, IMMX, CNTX, UNCY, IBIO, PMN, OKUR, XFOR, FHTX, ABSI, PEPG, CLYM, ERAS, ACET, CRDF, CCCC, ELDN, ADCT, TCRX IFRX, GOSS, ALMS, CABA, ZNTL, ACRS, PROK, CASI

UBS 2025 Global Healthcare Conference

The UBS 2025 Global Healthcare Conference will take place from November 10–12, 2025, bringing together a broad range of healthcare companies for a series of engaging presentations, fireside chats, and industry discussions. The event will provide institutional investors and stakeholders with insights into current healthcare trends, innovation pipelines, and strategic opportunities.

Participating Companies Include: GOSS, TMCI, CHRS, EDAP, NOTV, SABS, CLOV, CTKB, CATX, BFLY, SEER, CYH

Stifel 2025 Healthcare Conference

The Stifel 2025 Healthcare Conference is scheduled to take place from November 11–13, 2025, at the Lotte New York Palace Hotel in New York, NY, USA. This prominent event will bring together healthcare professionals, executives, and investors for in-depth discussions on innovative therapies, emerging treatment modalities, and sector-wide strategic developments. Attendees can expect a mix of company presentations, panel discussions, and networking sessions, offering valuable insights into the evolving healthcare and life sciences landscape.

Participating Companies Include: GERN, CMPS, SGHT, PYXS, PROF, MXCT, CGEN, RPID, IMMX, JSPR, ABCL, BDTX, ABOS, ALT, OABI, CRDF, NKTX, CNTX, ZNTL, VTGN, EQ, KLRS, ABEO, MGNX, SKYE, VNDA

Other Companies with Material Events This Week:

• TNYA will host a conference call on Monday, November 10, 2025, at 8:00 a.m. ET (5:00 a.m. PT) to discuss newly presented TN-201 data and provide an update on the MyPEAK-1 clinical trial.

• AVIR is scheduled to host a virtual key opinion leader (KOL) event on Thursday, November 13, 2025, at 10:00 a.m. ET. The event will explore key issues related to hepatitis C virus (HCV), including diagnosis, treatment strategies, public health policy, and the potential for HCV eradication in North America.

• IFRX expects to report topline data from its Phase 2a clinical trial evaluating oral C5aR inhibitor INF904 in hidradenitis suppurativa (HS) and chronic spontaneous urticaria (CSU) via a pre-market press release on Monday, November 10.

• MAIA will present a poster at SITC 2025 on November 10 titled “A Phase 2 Study of Ateganosine (THIO) in Combination with an Immune Checkpoint Inhibitor in Patients with Advanced NSCLC Resistant to Prior ICI and Chemotherapy.”

• XLO will host a conference call and webcast on Monday, November 10, 2025, at 4:30 p.m. ET to discuss new Phase 2 data on vilastobart and highlight the potential of high plasma TMB as a biomarker. The webcast will include expert insights from clinicians at Harvard Medical School and UPMC Hillman Cancer Center.

• MCRP will participate in DRIFTx, Abu Dhabi’s flagship smart and autonomous mobility exhibition, from November 10–12, 2025.

• ZENA has been invited to present to two VIP investor groups in Palm Beach, Florida, during the week of November 10–14, including a roundtable at The Mar-a-Lago Club, focused on growth opportunities in drone technology and services.

• IMNN will host an R&D Day in New York City on Monday, November 10, 2025, at 8:00 a.m. ET, featuring principal investigators from its ongoing Phase 3 and Phase 2 trials evaluating IMNN-001 for advanced ovarian cancer.

• PRSO will participate in the 2025 Africa Tech Festival in Cape Town, South Africa, from November 10–13, joining the Canadian Trade Commissioner Service to showcase Canadian innovation in digital technologies.

• BEEM will showcase its EV ARC™ and BeamBike™ off-grid EV and e-bike charging systems at DRIFTx from November 10–12 at Yas Marina Circuit in Abu Dhabi, as part of the region’s autonomous mobility week.

• NAUT will present at the 2025 HUPO World Congress on November 10, leading a seminar titled “Redefining Proteomics with Single-Molecule Iterative Mapping.”

• BZAI will participate in the AI Summit at Web Summit in Lisbon, Portugal, from November 10–13, 2025. Co-founder Val Cook will deliver a talk focused on AI software architecture.

• HITI will have executives present at an investor conference at Talman House in London on November 10, 2025.

• DVLT announced details of its Dream Bowl Draft, scheduled for January 11, 2026, at AT&T Stadium, along with a professional e-sports and drone racing championship. As part of the promotional campaign, DVLT will distribute commemorative Dream Bowl 2026 Meme Coins to shareholders of record as of November 14, 2025.

• CDXS will present at the 2025 TIDES Europe Annual Meeting in Basel, Switzerland, from November 11–13, highlighting developments in nucleic acid and peptide therapeutics.

• ZSPC will announce the global launch of the Inspire 2 Laptop at GESS Dubai 2025, from November 11–13, showcasing immersive learning tools for AR/VR without headsets.

• OXBR CEO Jay Madhu will speak on a panel titled “Tokenization and Stablecoins” at Uncorrelated Cayman 2025, on November 10 at Hotel Indigo Grand Cayman.

• ESPR will host a virtual KOL event on Tuesday, November 11, 2025, at 2:00 p.m. ET to discuss the unmet need in statin intolerance and emerging treatment approaches.

• MIST will present a poster on November 10 (10:30–11:30 a.m. CST) at the AHA Scientific Sessions 2025 in New Orleans, showing pooled data on efficacy and safety of etripamil nasal spray for PSVT.

• VTEX announced that Rafael Nadal will headline VTEX Connect Europe on November 11, 2025, at Pavilhão Carlos Lopes in Lisbon, Portugal.

• RCT will also participate in VTEX Connect Europe on November 11, with Co-Founder Soumaya Hamzaoui speaking on innovations in product management.

• SEGG announced Sports.com as title sponsor for Soccerex Miami 2025, taking place November 12–13 at the Miami Beach Convention Center. A senior SEGG delegation will attend, with executive appearances in leadership and talent development sessions.

• STRO will host a virtual R&D Day on Wednesday, November 12, 2025, at 10:00 a.m. ET, covering platform innovation and its next-generation ADC pipeline.

• ARTV will host a virtual event on Wednesday, November 12, 2025, at 8:00 a.m. ET to discuss early safety and translational data on AlloNK® in up to 32 patients with autoimmune disease.

• SLS CEO will participate in the J.P. Morgan U.S. Opportunities Forum on Wednesday, November 12, at the Kimpton EPIC Hotel in Miami.

• PRME will host a virtual KOL event at 8:00 a.m. ET on Wednesday, November 12, 2025, focused on its Wilson’s Disease strategy.

• ALDX will host a Research & Development Update webcast on Thursday, November 13, 2025, at 8:00 a.m. ET, featuring leadership team presentations on pipeline programs.

• SPWR will attend the Baird Industrials Conference in Chicago on November 13.

• ZBAO will host a Skyline Signature Series Webinar on November 13 at 12:00 p.m. ET, offering a platform for executive virtual presentations to financial professionals.

• TAIT declared a quarterly dividend of $0.035 per share, payable on November 26, 2025, to stockholders of record as of November 14.

• RPT declared a cash dividend of $0.06 per share, payable on November 28, 2025, to shareholders of record as of November 14.

• RGP approved a $0.07 per share dividend, payable on December 12, 2025, to shareholders of record on November 14.

• BTCS will participate in the Premier On-Chain Yield & Staking Conference, held November 15–16, 2025, at the Sheraton Buenos Aires Hotel in Argentina.

• OFAL is co-developing a digital platform for tokenizing real estate assets with BAF, leveraging AI and Web3. The pilot launch is expected to begin November 15, 2025.

• THAR will present a late-breaker poster at the AAPS PharmSci 360 Annual Scientific Meeting, taking place November 9–12 at the Henry B. Gonzalez Convention Center in San Antonio, TX.

• HTCR announced a one-time distribution of $0.13 per share, payable November 17, 2025, with a record date of November 10.

• XHLD signed a three-year agreement with Xcyte Digital Corporation to bundle and resell conferencing services. The agreement includes revenue-sharing terms and is contingent on finalizing escrow agreements by November 10, 2025.

• GPRO is awaiting the ITC’s Final Determination on November 10, 2025, regarding its IP infringement claims against Insta360. The outcome could be delayed due to the ongoing government shutdown.

Looking Ahead – Monday, November 17, 2025:

• SHFS CEO will speak at the IgniteIt Cannabis Capital and Policy Summit in Washington, D.C., at 2:30 p.m. ET on the topic of how federal cannabis reform could reshape capital markets and M&A.

• EDSA will present at the LSX Investival Showcase Europe in London at 3:45 p.m. GMT.

• XTIA will host a virtual Town Hall for investors, analysts, and media at 4:30 p.m. ET.

• MESA will hold a special shareholder meeting at 9:00 a.m. MST to vote on its merger with Republic Airways Holdings Inc., with the transaction expected to close by November 19.

• SRTA will host an Investor Day at the Nasdaq MarketSite in New York City beginning at 2:00 p.m. ET, featuring presentations from company leadership.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.